| | |
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C12H17BrN2O2 |
| Molar mass | 301.184 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
2,5-dimethoxy-4-bromophenylpiperazine (2C-B-PP) is a drug of the phenylpiperazine class. It acts as an agonist at serotonin receptors, and in studies on rats substituted for the psychedelic amphetamine derivative DOM with around 1/10 the potency but similar rates of stimulus-appropriate responding at the highest dose. [1] [2] : 867–868
| Phenylpiperazines |
|
|---|---|
| Benzylpiperazines | |
| Naphthylpiperazines | |
| Quinolinylpiperazines | |
| Diphenylalkylpiperazines |
|
| Pyrimidinylpiperazines | |
| Pyridinylpiperazines | |
| Benzo(iso)thiazolyl piperazines | |
| Tricyclic-linked piperazines |
|
| Others/uncategorized | |